Developmental disruption and restoration of brain synaptome architecture in the murine Pax6 neurodevelopmental disease model.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 11 2022
Historique:
received: 31 03 2022
accepted: 14 10 2022
pubmed: 12 11 2022
medline: 16 11 2022
entrez: 11 11 2022
Statut: epublish

Résumé

Neurodevelopmental disorders of genetic origin delay the acquisition of normal abilities and cause disabling phenotypes. Nevertheless, spontaneous attenuation and even complete amelioration of symptoms in early childhood and adolescence can occur in many disorders, suggesting that brain circuits possess an intrinsic capacity to overcome the deficits arising from some germline mutations. We examined the molecular composition of almost a trillion excitatory synapses on a brain-wide scale between birth and adulthood in mice carrying a mutation in the homeobox transcription factor Pax6, a neurodevelopmental disorder model. Pax6 haploinsufficiency had no impact on total synapse number at any age. By contrast, the molecular composition of excitatory synapses, the postnatal expansion of synapse diversity and the acquisition of normal synaptome architecture were delayed in all brain regions, interfering with networks and electrophysiological simulations of cognitive functions. Specific excitatory synapse types and subtypes were affected in two key developmental age-windows. These phenotypes were reversed within 2-3 weeks of onset, restoring synapse diversity and synaptome architecture to the normal developmental trajectory. Synapse subtypes with rapid protein turnover mediated the synaptome remodeling. This brain-wide capacity for remodeling of synapse molecular composition to recover and maintain the developmental trajectory of synaptome architecture may help confer resilience to neurodevelopmental genetic disorders.

Identifiants

pubmed: 36369219
doi: 10.1038/s41467-022-34131-w
pii: 10.1038/s41467-022-34131-w
pmc: PMC9652404
doi:

Substances chimiques

PAX6 protein, human 0
Pax6 protein, mouse 0
PAX6 Transcription Factor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6836

Subventions

Organisme : Wellcome Trust
ID : 202932/Z/16/Z
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Dev Neurobiol. 2011 Aug;71(8):690-709
pubmed: 21538923
J Consult Clin Psychol. 2007 Aug;75(4):594-604
pubmed: 17663613
Annu Rev Physiol. 2002;64:355-405
pubmed: 11826273
Nat Genet. 2015 May;47(5):448-52
pubmed: 25807282
Brain Res. 2021 Apr 1;1756:147283
pubmed: 33515537
iScience. 2018 Dec 21;10:171-191
pubmed: 30529950
Nat Neurosci. 2013 Jan;16(1):16-24
pubmed: 23201973
Lancet Psychiatry. 2016 Dec;3(12):1157-1165
pubmed: 27745869
Sci Rep. 2020 Feb 20;10(1):3062
pubmed: 32080308
J Autism Dev Disord. 2007 Oct;37(9):1735-47
pubmed: 17146700
Curr Opin Neurobiol. 2017 Aug;45:139-147
pubmed: 28577431
Eur J Neurosci. 2021 Oct;54(8):6864-6881
pubmed: 32492218
Genes Cells. 2005 Oct;10(10):1001-14
pubmed: 16164600
Eur J Neurosci. 2020 Feb;51(3):793-805
pubmed: 31621109
Genes (Basel). 2021 May 09;12(5):
pubmed: 34065151
J Neurosci. 1994 Mar;14(3 Pt 2):1395-412
pubmed: 8126546
Brain Res. 2019 Feb 15;1705:95-103
pubmed: 29499177
Am J Intellect Dev Disabil. 2011 Sep;116(5):381-97
pubmed: 21905806
J Physiol. 2008 Dec 15;586(24):5885-900
pubmed: 18936077
Nat Commun. 2022 Nov 11;13(1):6836
pubmed: 36369219
Annu Rev Biochem. 1994;63:487-526
pubmed: 7979246
PLoS One. 2017 Apr 11;12(4):e0175287
pubmed: 28399140
Nat Rev Genet. 2015 Jun;16(6):333-43
pubmed: 25963372
Annu Rev Biochem. 2015;84:435-64
pubmed: 25784053
Trends Genet. 2018 Mar;34(3):209-217
pubmed: 29269261
Nat Commun. 2016 Apr 27;7:11264
pubmed: 27117477
J Neurosci. 1997 Oct 15;17(20):7926-40
pubmed: 9315911
Nat Rev Neurosci. 2009 Mar;10(3):186-98
pubmed: 19190637
Br J Psychiatry. 1967 Nov;113(504):1183-99
pubmed: 6075452
Science. 2018 Sep 28;361(6409):1310-1311
pubmed: 30262483
Nat Rev Neurosci. 2021 Oct;22(10):627-636
pubmed: 34446866
Brain Struct Funct. 2013 Mar;218(2):353-72
pubmed: 22354470
Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):E8047-E8056
pubmed: 30082388
Am J Hum Genet. 2012 Dec 7;91(6):1022-32
pubmed: 23217326
Nat Rev Mol Cell Biol. 2019 Jul;20(7):421-435
pubmed: 30733602
Ann Clin Transl Neurol. 2016 Apr 12;3(5):314-30
pubmed: 27231702
J Neurosci. 2000 Sep 1;20(17):6501-16
pubmed: 10964956
Neuron. 2022 Sep 28;:
pubmed: 36202095
Neuropharmacology. 2016 Jan;100:47-55
pubmed: 26211975
Nat Neurosci. 2000 Jul;3(7):661-9
pubmed: 10862698
Mol Cell Proteomics. 2021;20:100016
pubmed: 33556866
Hum Genet. 2008 May;123(4):371-8
pubmed: 18322702
Cold Spring Harb Perspect Biol. 2015 Nov 02;7(11):
pubmed: 26525152
Semin Cell Dev Biol. 2019 Apr;88:67-79
pubmed: 29782925
Mol Syst Biol. 2009;5:269
pubmed: 19455133
J Neurosci. 2002 Nov 15;22(22):9721-32
pubmed: 12427827
PLoS One. 2016 Jun 29;11(6):e0158153
pubmed: 27355350
F1000Res. 2017 Mar 13;6:255
pubmed: 29034075
Nature. 1991 Dec 19-26;354(6354):522-5
pubmed: 1684639
PLoS One. 2016 Apr 28;11(4):e0153757
pubmed: 27124303
J Autism Dev Disord. 2010 Dec;40(12):1431-46
pubmed: 20361245
Cell. 1992 Jan 24;68(2):283-302
pubmed: 1346368
Nat Biotechnol. 2016 May;34(5):531-8
pubmed: 27065010
Sci Rep. 2016 Apr 25;6:24626
pubmed: 27109929
Development. 1997 May;124(10):1985-97
pubmed: 9169845
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):719-23
pubmed: 9012851
Eur J Neurosci. 2018 Jan;47(2):164-176
pubmed: 29237242
PLoS One. 2016 Nov 17;11(11):e0166665
pubmed: 27855195
J Exp Psychol Gen. 2013 May;142(2):573-603
pubmed: 22774788
Stem Cells. 2008 Jul;26(7):1663-72
pubmed: 18467663
J Am Acad Child Adolesc Psychiatry. 2012 Jun;51(6):622-31
pubmed: 22632621
Sci Rep. 2018 Jan 9;8(1):219
pubmed: 29317733
Front Cell Neurosci. 2015 Mar 10;9:70
pubmed: 25805971
Dev Biol. 2010 Aug 1;344(1):7-15
pubmed: 20435029
Hum Mov Sci. 2021 Aug;78:102823
pubmed: 34051667
Neuron. 2015 Aug 5;87(3):534-48
pubmed: 26247861
Cell Rep. 2017 Oct 17;21(3):679-691
pubmed: 29045836
Science. 2020 Jul 17;369(6501):270-275
pubmed: 32527927
J Neurosci. 2007 Mar 7;27(10):2673-82
pubmed: 17344405
Annu Rev Genet. 2020 Nov 23;54:189-211
pubmed: 32867542
Ment Retard Dev Disabil Res Rev. 2004;10(4):234-47
pubmed: 15666341
Neuron. 2018 Aug 22;99(4):781-799.e10
pubmed: 30078578
Epilepsia. 1998;39 Suppl 4:S32-41
pubmed: 9637591
PLoS Biol. 2022 Sep 6;20(9):e3001563
pubmed: 36067211
Nature. 1998 Dec 3;396(6710):433-9
pubmed: 9853749

Auteurs

Laura Tomas-Roca (L)

Genes to Cognition Program, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.

Zhen Qiu (Z)

Genes to Cognition Program, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.

Erik Fransén (E)

Science for Life Laboratory, KTH Royal Institute of Technology, SE-171 65, Solna, Sweden.

Ragini Gokhale (R)

Genes to Cognition Program, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.

Edita Bulovaite (E)

Genes to Cognition Program, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.

David J Price (DJ)

Simons Initiative for the Developing Brain (SIDB), Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.

Noboru H Komiyama (NH)

Genes to Cognition Program, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK.
Simons Initiative for the Developing Brain (SIDB), Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK.

Seth G N Grant (SGN)

Genes to Cognition Program, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, EH16 4SB, UK. seth.grant@ed.ac.uk.
Simons Initiative for the Developing Brain (SIDB), Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK. seth.grant@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH